London-based Perceptic, which says its end-to-end AI platform for drug development is being used by top pharmaceuticals, raised a $12M seed led by Accel (Jeremy Kahn/Fortune)

<a href="https://fortune.com/2026/05/26/exclusive-perceptic-a-startup-automating-drug-discovery-end-to-end-for-big-pharma-emerges-from-stealth-with-12-million-in-seed-funding/"><img align="RIGHT" border="0" hspace="4" src="http://www.techmeme.com/260526/i28.jpg" vspace="4" /></a> <p><a href="https://www.techmeme.com/260526/p28#a260526p28" title="Techmeme permalink"><img height="12" src="http://www.techmeme.com/img/pml.png" style="border: none; padding: 0; margin: 0;" width="11" /></a> Jeremy Kahn / <a href="http://www.fortune.com/">Fortune</a>:<br /> <span style="font-size: 1.3em;"><b><a href="https://fortune.com/2026/05/26/exclusive-perceptic-a-startup-automating-drug-discovery-end-to-end-for-big-pharma-emerges-from-stealth-with-12-million-in-seed-funding/">London-based Perceptic, which says its end-to-end AI platform for drug development is being used by top pharmaceuticals, raised a $12M seed led by Accel</a></b></span>&nbsp; &mdash;&nbsp; A trio of former Palantir executives who helped spearhead that company's Life Sciences practice have founded a startup called Perceptic &hellip; </p>